...
首页> 外文期刊>Perfusion >Aortic valve replacement with or without myocardial revascularization in octogenarians. Can minimally invasive extracorporeal circuits improve the outcome?
【24h】

Aortic valve replacement with or without myocardial revascularization in octogenarians. Can minimally invasive extracorporeal circuits improve the outcome?

机译:主动脉瓣在八十型血管内替代或没有心肌血运重建。 最微创的体外电路可以改善结果吗?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: The positive impact of minimally invasive extracorporeal circuits (MiECC) on patient outcome is expected to be most evident in patients with limited physiologic reserves. Nevertheless, most studies have limited their use to low-risk patients undergoing myocardial revascularization. As such, there is little evidence to their benefit outside this patient population. We, therefore, set out to explore their potential benefit in octogenarians undergoing aortic valve replacement (AVR) with or without concomitant myocardial revascularization. Methods: Based on the type of the utilized ECC, we performed a retrospective propensity score-matched comparison among all octogenarians (n = 218) who received a primary AVR with or without concomitant coronary artery bypass grafting in our institution between 2003 and 2010. Results: A MiECC was utilized in 32% of the patients. The propensity score matching yielded 52 matched pairs. The 30-day postoperative mortality (2% vs. 10%; p=0.2), the incidence of low cardiac output (0% vs. 6%; p=0.2) and the Intensive Care Unit (ICU) stay (2.5 ± 2.6 vs. 3.8 ± 4.7 days; p=0.06) were all in favour of the MiECC group, but failed to reach statistical significance while the 90-day postoperative mortality did (2% vs. 16%; p=0.02). Conclusion: MiECCs have a positive influence on the outcome of octogenarians undergoing AVR with or without concomitant coronary artery bypass grafting. Their use should, therefore, be extended beyond isolated coronary artery bypass graft (CABG) surgery.
机译:目的:最微创体外电路(MIECC)对患者结果的积极影响预计将在有限的生理储备患者中最明显。尽管如此,大多数研究都限制了他们对经历心肌血运重建的低风险患者的用途。因此,在患者群体之外的利益几乎没有证据。因此,我们列出了探讨其在八十型血管瓣膜置换(AVR)的八十型心肌血运重建中的潜在益处。方法:基于所使用的ECC的类型,我们在2003年至2010年期间,在所有八次遗传率(n = 218)中,在所有八十八岁的情况下,在所有八十岁的情况下进行了回顾性倾向比较的比较。结果:32%的患者使用MIECC。倾向得分匹配产生52对成对。 30天的术后死亡率(2%对10%; P = 0.2),低心输出的发病率(0%对6%; P = 0.2)和重症监护室(ICU)停留(2.5±2.6与3.8±4.7天; p = 0.06)都赞成MIECC组,但未能达到统计学意义,而90天的术后死亡率(2%对16%; P = 0.02)。结论:MIECC对八十八种AVR的结果具有积极影响,或没有伴随的冠状动脉旁路接枝。因此,它们的使用应该延伸超越孤立的冠状动脉旁路移植物(CABG)手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号